Pharos iBio (388870) | AccidentalOrder

KOSDAQ · 5,420 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

70.2B

Op Inc (2025)

-11.5B

Net Inc (2025)

-10.8B

PBR

5.04

52W

4K~11K

Pharos iBio operates in the Professional Services sector.

Legal name: Pharos iBio Co., Ltd.

Operating profit was -11.5 billion KRW and net income was -10.8 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 70.2 billion KRW, with a P/B of 5.04.

These figures can be verified in the DART filing (receipt no. 20260319001312).

Year	Rev	Op Inc	Net Inc
2025	—	-11.5B	-10.8B
2024	—	-12.6B	-10.6B
2023	—	-10.1B	-8.9B

2 applicable out of 8 items

Semi-Annual Report (2026.06)

Checks

2 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 1 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.1% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: No market actions recorded in the last 180 days.

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-13	Semi-Annual Report (2026.06)